Avemar – A Great Cancer Killer!

Avemar is a naturally fermented wheat germ extract that has been subjected to a great deal of research scrutiny, particularly in the area of cancer treatment. What makes Avemar excel among other known therapies is the fact that its effectiveness isn’t limited to any one specific type of cancer. So far it has exhibited positive effects against all forms of cancer cell lines tested. Avemar works on several fronts. It not only acts as an immune system “booster,” it also has the ability to help protect the immune system from the damaging consequences of chemotherapy and radiation. What credibly sets it apart from most other therapies, however, is its ability to inhibit glucose metabolism in cancer cells.

Glucose metabolism in cancer is one topic that you’ll being hearing a lot about in the upcoming years. Every form of cancer cell requires significant amounts of glucose of 10 to 50 times more than normal healthy cells. Conversion of the glucose produces nucleic acids and proteins which are the building materials that a cancer requires to continue growing. This process is referred to as the Warburg effect. More and more research studies are revealing that many cancer therapies that have a positive effect because they inhibit glucose metabolism in tumor cells. And Avemar happens to be one of these.

One of the latest studies concerning Avemar addressed with breast cancer. This past July, researchers presented the findings of a recent study at the annual American Society of Clinical Oncology meeting, where Avemar was compared to the most widely used drug therapies for breast cancer like tamoxifen, Aromasin, and Arimidex, all of which affect either a woman’s level of estrogen or the ability of her body to respond to estrogens. The results of this head-to-head comparison sent some shock-waves throughout the cancer treatment community.

Avemar inhibited the growth of one type of estrogen sensitive breast cancer by 50 percent, compared to tamoxifen’s 34 percent. In a second type of estrogen-sensitive breast tumor. And Avemar inhibited the growth by 49 percent, compared to tamoxifen’s 42 percent. Avemar was also shown to work better than either of the other two drugs, Aromasin or Arimidex. When Avemar was used along with the conventional drug therapies, it increased their ability to inhibit or slow the tumor growth by an additional 5 to 10 percent in one of the estrogen-sensitive tumor types.

One other very important fi nding was that Avemar was also able to inhibit tumor growth in forms of breast cancer that are not estrogen-dependent. None of the other three conventional drugs had any effect. From a practical standpoint, this study showed that none of the pharmaceutical anti-estrogen drugs were as eff ective as Avemar alone. This report is from Journal of Clinical Oncology. Through its ability to impede glucose metabolism and the formation of DNA in cancer cells, Avemar slows cancer cell division and tumor growth. Research has now shown that Avemar also triggers cancer cell “suicide” and makes the cancer more recognizable to the immune system. All of these factors work in harmony with the body to destroy the cancer and this is without toxic side effects or damaging normal, healthy cells as many other treatments do. This latest information is vital for anyone with breast cancer, those who have been treated with hormone therapy for breast cancer, and individuals who are at high risk of developing breast cancer due to genetic factors. The body of research supporting Avemar continues to grow.

Avemar is sold under the brand name of Avé in the US and is available from t Harmony Company, at 888-809-1241 or www.theharmonyco.com.